Db. Tumas et al., Anti-IgE efficacy in murine asthma models is dependent on the method of allergen sensitization, J ALLERG CL, 107(6), 2001, pp. 1025-1033
Background: Murine models used to delineate mechanisms and key mediators of
asthma have yielded conflicting results and suggest that the dominant mech
anism and mediators required for disease induction differ depending on the
model and method of allergen sensitization used.
Objective: The goal of this study was to determine whether the mode of alle
rgen sensitization influenced the role that IgE had in allergen-induced pul
monary eosinophilic inflammation.
Methods: Mice were exposed to dust mite extract in 2 models of allergic inf
lammation that differed in the method of sensitization, We compared sensiti
zation by aerosol exposure with and without concomitant human respiratory s
yncytial virus infection with sensitization by means of systemic (intraperi
toneal) exposure with adjuvant, After sensitization, animals were similarly
challenged with aerosolized allergen. Animals were treated with anti-IgE m
Ab to deplete IgE and to determine its role in the induction of allergic in
flammation and mucosa pathology in these models.
Results: Concomitant respiratory syncytial virus infection significantly en
hanced allergen sensitization by aerosol exposure and exacerbated eosinophi
lic inflammation and airway mucosa pathology. Depletion of IgE in this mode
l significantly reduced lung eosinophilic inflammation and airway mucose pa
thology, However, in the model in which animals were sensitized by means of
systemic allergen exposure with adjuvant, depletion of IgE had no ameliora
tive effect on lung inflammation or pathology,
Conclusion: We demonstrated that the method of antigen sensitization can de
lineate the role of IgE in allergen-induced lung inflammation. In a murine
model that more closely resembles ambient allergen exposure in human subjec
ts, IgE had a critical role in the pathogenesis of allergic asthma and muco
sa pathology. The results parallel the results reported with anti-IgE effic
acy in allergic asthmatic human subjects.